|
2025 Journal Article Transperineal prostate biopsy under local vs general anaesthesia: a cost-effectiveness analysisRoberts, Matthew J., Arora, Shiksha, Yao, Henry H., Hogan, Donnacha, Dias, Brendan, O'Connell, Helen E., Wetherell, David, Zargar, Homayoun, Kwok, Michael, McGeorge, Stephen P., Pearce, Adam, Yaxley, John and Tuffaha, Haitham (2025). Transperineal prostate biopsy under local vs general anaesthesia: a cost-effectiveness analysis. BJU international, 1-7. doi: 10.1111/bju.16722 |
|
2025 Journal Article Telehealth-Delivered Exercise to Promote Health after Gynecological Cancer Therapy: A Randomized Waitlist-Controlled TrialCunningham, Brent, Porter-Steele, Janine, Hayes, Sandra C., Chiu, Vivian, Clifford, Briana K., Rose, Grace L., Jones, Caroline L., Bailey, Tom G., Young, Leonie, Garrett, Andrea, Nicklin, James, Khan, Asaduzzaman, Tuffaha, Haitham and McCarthy, Alexandra L. (2025). Telehealth-Delivered Exercise to Promote Health after Gynecological Cancer Therapy: A Randomized Waitlist-Controlled Trial. Translational Journal of the American College of Sports Medicine, 10 (2) e000307, 1-6. doi: 10.1249/tjx.0000000000000307 |
|
2025 Journal Article Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping reviewPak, Anton, O'Grady, Madeline, Holtmann, Gerald, Shah, Ayesha and Tuffaha, Haitham (2025). Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review. PharmacoEconomics, 43 (3) e14578, 249-269. doi: 10.1007/s40273-024-01455-y |
|
2024 Conference Publication Developing economic evaluation guidelines for Saudi Arabia – local experts engagementMaraiki, F., Elhassan, T., Bazarbashi, S., Scuffham, P. and Tuffaha, H. (2024). Developing economic evaluation guidelines for Saudi Arabia – local experts engagement. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17 – 20 November 2024. New York, NY, United States: Elsevier. doi: 10.1016/j.jval.2024.10.2178 |
|
2024 Conference Publication The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L. and Tuffaha, H. (2024). The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17-20 November 2024. New York, United States: Elsevier. doi: 10.1016/j.jval.2024.10.610 |
|
2024 Conference Publication A roadmap to the use of value of information analysis in health technology assessment: an international study of barriers, facilitators, and potential applicationsGrimm, S., Glynn, D., Coyle, D., Jalal, H., Koffijberg, E., Tuffaha, H., Vervaart, M., Welton, N.J., Wilson, E., Rothery, C. and Kunst, N. (2024). A roadmap to the use of value of information analysis in health technology assessment: an international study of barriers, facilitators, and potential applications. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17 – 20 November 2024. New York, NY, United States: Elsevier. doi: 10.1016/j.jval.2024.10.2049 |
|
2024 Other Outputs MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR)Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR). Canberra, ACT Australia: Commonwealth of Australia. |
|
2024 Conference Publication Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation frameworkWang, Yufan, McCarthy, Sandie and Tuffaha, Haitham (2024). Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13–15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2024 Conference Publication Prostate cancer survivorship essentials for men with prostate cancer on androgen deprivation therapy: Protocol of an effectiveness-implementation hybrid (type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study)Green, Anna, Newton, Rob U., Chambers, Suzanne K., Smith, David P., Tuffaha, Haitham, Galvao, Daniel A., Heathcote, Peter, Patel, Manish I., Christie, David, Egger, Sam, Sara, Sally A. M., Heneka, Nicole and Dunn, Jeff (2024). Prostate cancer survivorship essentials for men with prostate cancer on androgen deprivation therapy: Protocol of an effectiveness-implementation hybrid (type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study). COSA's 51st Annual Scientific Meeting: Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.14117 |
|
2024 Journal Article The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019 |
|
2024 Conference Publication The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysisObermair, Andreas, West, Zoe, Baxter, Eva, Condous, George, Hacker, Neville, Lord, Sally, Mccarthy, Sandie, Janda, Monika, Tuffaha, Haitham, Hayes, Sandi, Disipio, Tracey, Mellon, Anne, Gebski, Val, Mcnally, Orla and Martin, Andrew (2024). EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis. IGCS 2024 Annual Meeting, Dublin, Ireland, 16-18 October 2024. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2024-igcs.551 |
|
2024 Journal Article Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocolFerris, Laura J., Ludlow, Kristiana, Walker, Nicole, Georgiou, Andrew, Henry, Julie D., Lopez Silva, Claudia, Ha, Diep H., Stormon, Nicole, Walsh, Laurence J., Ivanovski, Saso, Sexton, Christopher, Silveira Schuch, Helena, Tuffaha, Haitham, Zamora, Angelique, Pritchard, Lyndal and Do, Loc G. (2024). Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocol. Healthcare, 12 (19) 1953, 1-10. doi: 10.3390/healthcare12191953 |
|
2024 Conference Publication Early learnings from a national trial of a consumer and clinician developed survivorship care intervention for men with prostate cancer on androgen deprivation therapy (PCEssentials Hormone Therapy Study)Green, A., Newton, R. U., Chambers, S., Smith, D. P., Tuffaha, H., Galvao, D. A., Heathcote, P., Patel, M., Christie, D., Egger, S., Sara, S. A., Heneka, N. and Dunn, J. (2024). Early learnings from a national trial of a consumer and clinician developed survivorship care intervention for men with prostate cancer on androgen deprivation therapy (PCEssentials Hormone Therapy Study). World Cancer Congress, Geneva, Switzerland, 17–19 September 2024. Hoboken, NJ, United States: John Wiley & Sons. |
|
2024 Other Outputs MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of AustraliaHettiarachchi, Ruvini and Tuffaha, Haitham (2024). MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia. Canberra, ACT Australia: Commonwealth of Australia. |
|
2024 Other Outputs MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO ConfirmationYeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation. Canberra, ACT Australia: Commonwealth of Australia. |
|
2024 Journal Article A preference-based value framework to assess healthcare provision in an oil and gas industryPak, Anton, Pols, Thomas, Kondalsamy-Chennakesavan, Srinivas, McGrail, Matthew, Gurney, Tiana, Fox, Jordan L. and Tuffaha, Haitham (2024). A preference-based value framework to assess healthcare provision in an oil and gas industry. Australian Health Review, 48 (5), 524-529. doi: 10.1071/ah24111 |
|
2024 Journal Article Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilotHeneka, Nicole, Chambers, Suzanne K., Schaefer, Isabelle, Carmont, Kelly, Parcell, Melinda, Wallis, Shannon, Walker, Stephen, Tuffaha, Haitham, Steele, Michael and Dunn, Jeff (2024). Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot. Australian Journal of Rural Health, 32 (4), 815-826. doi: 10.1111/ajr.13149 |
|
2024 Journal Article The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancerTeppala, Srinivas, Scuffham, Paul A. and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer. International Journal of Technology Assessment in Health Care, 40 (1) e14, 1-9. doi: 10.1017/s0266462324000011 |
|
2024 Other Outputs MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO ConfirmationYeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation. Canberra, ACT, Australia: Commonwealth of Australia. |
